Stay Updated
For all press requests, please reach out to [email protected].
Press Releases
Patients For Affordable Drugs Reacts to New White House MFN Agreements
WASHINGTON, D.C. — The White House today announced agreements with nine additional pharmaceutical corporations as part of the administration’s Most Favored Nation (MFN) drug pricing strategy. Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB have agreed to provide Medicaid programs access to MFN drug prices on their products. […]
News and Reports
Epoch Times: Appeals Court Upholds Medicare Drug Price Negotiation Program
Merith Basey, CEO of the advocacy group Patients For Affordable Drugs, hailed the ruling in an Aug. 27 statement. “For decades, the pharmaceutical industry prevented Medicare from negotiating a better deal for American patients and taxpayers,” Basey said. “Now Congress has both the responsibility and an urgent opportunity to build on this overwhelmingly popular program […]
News and Reports
“This fight has always been about power. For decades, the pharmaceutical industry prevented Medicare from negotiating a better deal for American patients and taxpayers,” said Merith Basey, the CEO of advocacy group Patients for Affordable Drugs, in a statement about the ruling. “The 5th Circuit’s decision marks the 25th courtroom victory for patients and sends […]
News and Reports
The Hill: Federal court rejects PhRMA challenge to Medicare drug price negotiation
Patient advocacy groups celebrated the ruling. “PhRMA has been at the center of the industry’s years-long, multi-million-dollar legal campaign to overturn Medicare negotiation. Now, they’ve lost one of their most significant challenges to the program to date. The Fifth Circuit rejected this sweeping constitutional attack, delivering the 25th courtroom victory for Medicare negotiation and the […]
Press Releases
PhRMA’s Medicare Drug Price Negotiation Challenge Rejected by Fifth Circuit U.S. Court of Appeals
Industry’s challenges have now been rejected by the Second, Third, Fifth, and D.C. Circuits. WASHINGTON, D.C. — Yesterday, the U.S. Court of Appeals for the Fifth Circuit rejected a challenge to the Medicare negotiation program brought by Pharmaceutical Research and Manufacturers of America (PhRMA), the National Infusion Center Association, and the Global Colon Cancer Association […]
News and Reports
Monday’s ruling was welcomed by advocacy group Patients for Affordable Drugs, whose director of media and communications, Emma Sands, said the pharma industry has spent three years and millions of dollars fighting the programme. “Again and again, their arguments have failed in the courtroom,” Sands said. “This is a win for patients who fought for […]
News and Reports
Fierce Pharma: Merck, AZ lawsuits against Medicare price negotiations swatted down
Monday’s decision against Merck was heralded by U.S. advocacy group Patients for Affordable Drugs, whose director of media and communications, Emma Sands, said in a statement that the pharma industry has spent three years and millions of dollars fighting to overturn a program she argued is “overwhelmingly supported by American patients and Taxpayers.” “Again and […]
Press Releases
D.C. Federal Court Rejects Merck’s Challenge To Medicare Drug Price Negotiation
Today’s decision marks the 24th ruling against Big Pharma and in favor of patients. WASHINGTON, D.C. — The U.S. District Court for the District of Columbia rejected Merck’s challenge to the Medicare Drug Price Negotiation Program, handing patients another major legal victory and rejecting another pharmaceutical corporation’s attempt to dismantle the historic program that’s already […]